About Kent Kirshenbaum
Kent is a gifted chemist, inventor and scientific speaker and helps tell the story of the unique mechanism of action of Maxwell’s compounds to clinical and scientific audiences. As a co-inventor of the drug class, he is able to answer questions regarding the fundamental chemical science behind the discovery of the drug class and ongoing scientific research collaborations with academic institutions around the world. He facilitates new avenues for scientific collaboration for the study of biomimetic therapeutics that may have major impacts in medically unmet needs in humans and agriculture.
The Kirshenbaum Lab was recently awarded a large grant from the New York State Biodefense Fund to develop an independent pandemic response system for New York based on Maxwell’s Claromer pathogen-agnostic anti-infective technology. He is also a successful DARPA awardee to create what DARPA called a “synthetic immune system.”
Related Organizations
